Cognitive, Psychological and Electrophysiological Attributes to Suicide Among Depressed Patients

April 24, 2020 updated by: Shady Mashaly, Mansoura University
This study will try to provide a better understanding of the psychological, cognitive and electrophysiological factors that contribute to suicide in depressed patients.

Study Overview

Detailed Description

Objectives:

  1. To investigate the ability of qEEG to suspect suicidal potential in patients diagnosed with major depression.
  2. To test the ability of some psychological and cognitive elements in determining the likelihood of suicide in such patients.
  3. To give an objective and more reliable method than traditional questionnaires to assess the seriousness of suicidal ideations in patients suffering from depression who usually don't reveal their actual intentions.

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Dakahlia
      • Mansoura, Dakahlia, Egypt, 35516

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

50 Egyptian patients will be recruited from Mansoura University Hospitals at the outpatient clinics and the inpatient department.

Description

Inclusion Criteria:

  • Age between 16 and 65 years
  • Both males and females will be enrolled
  • Patients present with the clinical picture of Major depression according to DSM 5 criteria.

Exclusion Criteria:

  • Psychotic features associating depressive episode
  • Bipolar depression
  • The condition is due to another medical condition
  • The condition is substance or medication-induced
  • Intellectual disability
  • Comorbid epilepsy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Study Group (MDD with SIs)
25 Egyptian patients diagnosed with major depression (with suicidal ideations)
  1. Both groups will undergo evaluation of depression severity using Beck Depression Inventory Scale-II (Arabic Version)
  2. Both groups will be assessed for psychological & cognitive contributes respectively using:

    A. Connor and Davidson Scale for resilience (Arabic Version) B. The scale of Islamic Religiosity Attitude (SIRA)

  3. Both groups will do Quantitative EEG (qEEG) to detect electrical, functional and brain mapping changes {Using Neurovirtual BW III, Florida, USA)
  4. The quantitative analysis of EEG will focus on the following functions:

Histogram, Topography, Spectrum Analysis, Spectral Differences, Propagation, Positional Diagram, Medium Amplitude, Ranges of Absolute Frequencies, Ranges of Relative Frequencies, CSA, Spectrum, and CSA Compressed.

Other Names:
  • Resilience scale (Carl & Davidson) Arabic version
  • BDI (Beck Inventory II) Arabic version
  • Suicide probability Scale (Arabic Version)
  • Scale of Islamic Religiosity Attitude (SIRA)
Control group (MDD without SIs)
25 Egyptian patients diagnosed with major depression (without suicidal ideations)
  1. Both groups will undergo evaluation of depression severity using Beck Depression Inventory Scale-II (Arabic Version)
  2. Both groups will be assessed for psychological & cognitive contributes respectively using:

    A. Connor and Davidson Scale for resilience (Arabic Version) B. The scale of Islamic Religiosity Attitude (SIRA)

  3. Both groups will do Quantitative EEG (qEEG) to detect electrical, functional and brain mapping changes {Using Neurovirtual BW III, Florida, USA)
  4. The quantitative analysis of EEG will focus on the following functions:

Histogram, Topography, Spectrum Analysis, Spectral Differences, Propagation, Positional Diagram, Medium Amplitude, Ranges of Absolute Frequencies, Ranges of Relative Frequencies, CSA, Spectrum, and CSA Compressed.

Other Names:
  • Resilience scale (Carl & Davidson) Arabic version
  • BDI (Beck Inventory II) Arabic version
  • Suicide probability Scale (Arabic Version)
  • Scale of Islamic Religiosity Attitude (SIRA)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electrophysiological attibutes to suicide among depressed patients
Time Frame: 5 months
Quantitative Analysis of EEG tracing from depressed patients experiencing suicidal Ideations
5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2019

Primary Completion (Anticipated)

July 15, 2020

Study Completion (Anticipated)

August 1, 2020

Study Registration Dates

First Submitted

September 24, 2019

First Submitted That Met QC Criteria

September 24, 2019

First Posted (Actual)

September 26, 2019

Study Record Updates

Last Update Posted (Actual)

April 28, 2020

Last Update Submitted That Met QC Criteria

April 24, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

I am planning to include a foreigner supervisor on my thesis.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide

Clinical Trials on Quantitative EEG

3
Subscribe